Separately, HC Wainwright raised their target price on ProPhase Labs from $14.00 to $15.00 and gave the stock a “buy” rating in a research report on Friday, November 11th.
ProPhase Labs Stock Up 2.1 %
Shares of NASDAQ:PRPH opened at $8.84 on Thursday. The firm has a market cap of $143.90 million, a P/E ratio of 4.86 and a beta of -0.26. The company has a quick ratio of 3.92, a current ratio of 4.21 and a debt-to-equity ratio of 0.12. ProPhase Labs has a 12-month low of $6.20 and a 12-month high of $15.25. The business has a fifty day simple moving average of $10.02 and a 200 day simple moving average of $10.99.
Institutional Trading of ProPhase Labs
Large investors have recently bought and sold shares of the business. Bailard Inc. acquired a new stake in ProPhase Labs during the 3rd quarter worth about $126,000. Precision Wealth Strategies LLC acquired a new stake in ProPhase Labs during the 2nd quarter worth about $152,000. Goldman Sachs Group Inc. acquired a new stake in ProPhase Labs during the 2nd quarter worth about $164,000. Cambridge Investment Research Advisors Inc. acquired a new stake in ProPhase Labs during the 2nd quarter worth about $168,000. Finally, Cubist Systematic Strategies LLC grew its holdings in ProPhase Labs by 7.9% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 16,537 shares of the company’s stock worth $187,000 after acquiring an additional 1,205 shares during the period. 9.75% of the stock is currently owned by institutional investors and hedge funds.
ProPhase Labs Company Profile
ProPhase Labs, Inc is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment.
- Get a free copy of the StockNews.com research report on ProPhase Labs (PRPH)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.